Clinical Scorecard: Emergency Department Use Among Women Veterans: Patterns and Factors Associated With VA and Community Care
At a Glance
Category
Detail
Condition
Emergency department utilization among women Veterans enrolled in VA healthcare
Key Mechanisms
The article notes that proximity, perceived quality, and financial considerations can influence decisions about receiving emergency care at VA or Community Care locations.
Target Population
Veterans enrolled in VA healthcare with at least one VA or Community Care emergency department visit during fiscal year 2023; analyses examined women Veterans and comparisons with men.
Care Setting
VA and community emergency departments.
Key Highlights
The retrospective cohort study evaluated emergency department use during fiscal year 2023 among VA-enrolled Veterans.
The study compared VA versus community emergency department use by sex and examined factors associated with setting among women Veterans.
The study identified emergency department diagnoses and assessed encounter disposition, emergency care-sensitive conditions, behavioral health, and acuity.
The introduction describes insufficient information about Community Care eligibility and apprehension about out-of-pocket expenses as obstacles to community emergency care.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
VA-enrolled Veterans aged 18 to 110 years with at least one VA or Community Care emergency department visit in fiscal year 2023; patients outside this age range and encounters without a primary diagnosis code were excluded.
The supplied article text describes emergency care utilization and study methods but does not provide treatment or prescribing findings.
by Jessica Faiz, Christopher J. Carvalho, Tracy Urech, Siqi Wu, Jessica Y. Breland, Susan M. Frayne, Donna L. Washington, Kristina M. Cordasco, Anita A. Vashi
In an exploratory subgroup analysis of patients with ESR1-mutated tumors, median progression-free survival was 11.1 months with the combination and 5.5 months with imlunestrant alone.
